文献速递帕金森病与运动障碍

多巴胺转运体显像不能预测帕金森病黑质神经元数量

Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease.
PubMed 文献 · Neurology · 2017-03-10

该队列研究对18例生前接受多巴胺转运体SPECT检查的患者(其中11例神经病理确诊帕金森病)死后计算黑质神经元数量,分析纹状体特异性结合比与黑质酪氨酸羟化酶阳性及含神经黑色素神经元计数的相关性。结果显示平均壳核特异性结合比与黑质神经元数量无显著相关,提示纹状体多巴胺转运体结合可能反映轴突功能障碍或转运体表达而非存活神经元数量。

要点

  • 帕金森病患者纹状体多巴胺转运体结合与黑质神经元数量无显著相关。
  • 多巴胺转运体显像可能反映轴突功能障碍或转运体表达而非神经元存活。
  • 一定损伤水平后,黑质神经元数量与纹状体多巴胺可能不再相关。

核心结论

  • 死后黑质致密部神经元计数与纹状体多巴胺转运体结合无关联。
  • 纹状体多巴胺转运体结合可能反映轴突功能障碍或转运体表达而非存活神经元数量。

研究设计与样本

  • 队列研究,对18例生前接受多巴胺转运体SPECT检查的患者死后计算黑质神经元数量,其中11例为神经病理确诊的帕金森病。
  • 采用基于感兴趣区的半定量分析和基于体素的分析,进行黑质酪氨酸羟化酶阳性及含神经黑色素神经元计数与纹状体特异性结合比的相关性分析。

主要发现

  • 平均壳核特异性结合比与黑质酪氨酸羟化酶阳性神经元数量无相关(r = -0.11,p = 0.66)。
  • 平均壳核特异性结合比与黑质含神经黑色素神经元数量无相关(r = -0.07,p = 0.78)。
  • 以SPECT与死亡时间间隔为协变量、采用基于体素的分析或仅纳入帕金森病患者时,相关性均无显著意义。

临床怎么用

  • 多巴胺转运体显像不宜用于推断帕金森病患者黑质神经元存活数量。
  • 临床解读多巴胺转运体显像结果时,应考虑其可能反映轴突功能障碍或转运体表达而非神经元计数。

局限性

  • 样本量较小(18例,其中帕金森病11例)。
  • SPECT检查与死亡之间存在时间间隔。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine possible associations between in vivo brain dopamine transporter SPECT imaging and substantia nigra pars compacta (SNc) neuronal survival in Parkinson disease (PD). METHODS: Nigral neuron numbers were calculated for 18 patients (11 patients with neuropathologically confirmed PD) who had been examined with dopamine transporter (DAT) SPECT before death. Correlation analyses between SNc tyrosine hydroxylase (TH)-positive and neuromelanin-containing neuron counts and DAT striatal specific binding ratios (SBRs) were performed with semiquantitative region of interest-based and voxel-based analyses. RESULTS: Mean putamen SBR did not correlate with the number of substantia nigra TH-positive (r = -0.11, p = 0.66) or neuromelanin-containing (r = -0.07, p = 0.78) neurons. Correlations remained clearly nonsignificant when the time interval between SPECT and death was used as a covariate, when the voxel-based analysis was used, and when only patients with PD were included. CONCLUSIONS: This cohort study demonstrates that postmortem SNc neuron counts are not associated with striatal DAT binding in PD. These results fit with the theory that there is no correlation between the number of substantia nigra neurons and striatal dopamine after a certain level of damage has occurred. Striatal DAT binding in PD may reflect axonal dysfunction or DAT expression rather than the number of viable neurons.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Saari L, Kivinen K, Gardberg M, et al. Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease. Neurology. 2017. PMID: 28283599. doi:10.1212/WNL.0000000000003810

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。